The effects of Escherichia coli capsule, O-antigen, host neutrophils, and complement in a rat model of Gram-negative pneumonia

FEMS Microbiology Letters

Volumn 226, Issue 2, 2003, Pages 355-361

  Russo, Thomas A ^a,b   Davidson, Bruce A ^a,b   Carlino MacDonald, Ulrike B ^a,b   Helinski, Jadwiga D ^a,b   Priore, Roger L ^b   Knight III, Paul R ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Capsule; Complement; Escherichia coli; Lung injury; Neutrophil; O antigen; Pathogenesis; Pneumonia

Indexed keywords

COMPLEMENT; LIPOPOLYSACCHARIDE; O ANTIGEN; BACTERIAL POLYSACCHARIDE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; ESCHERICHIA COLI; HOST RESISTANCE; LD 50; LUNG CLEARANCE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; RAT; WILD TYPE; ANIMAL; BACTERIAL GENE; BACTERIAL PNEUMONIA; DISEASE MODEL; ENTEROBACTER INFECTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY;

ANIMALIA; BACILLI; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

ANIMALS; BACTERIAL CAPSULES; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENES, BACTERIAL; MUTAGENESIS, INSERTIONAL; NEUTROPHILS; O ANTIGENS; PNEUMONIA, BACTERIAL; POLYSACCHARIDES, BACTERIAL; RATS; VIRULENCE FACTORS;

EID: 0642346957     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(03)00636-0     Document Type: Article

References (41)

1. Cook D., et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. New Engl. J. Med. 338:1998;791-797.
2. Craven D., Barber T., Steger K., Montecalvo M. Nosocomial pneumonia in the 1990s: Update of epidemiology and risk factors. Sem. Respir. Infect. 5:1990;157-172.
3. Centers for Disease Control (1984) National nosocomial infections study report. Annual summary 1984. MMWR 35, 17SS-29SS.
4. Emori T., Gaynes R. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6:1993;428-442.
5. Lynch J.I. Hospital-acquired pneumonia. Chest. 119:2001;373S-384S.
6. Chastre J., Fagon J.-Y. Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 165:2002;867-903.
7. Craven D., Steger K. Epidemiology of nosocomial pneumonia. New perspectives on an old disease. Chest Suppl. 108:1995;1S-16S.
8. American Thoracic Society (1996) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, November 1995. Am. J. Respir. Crit. Care Med. 153, 1711-1725.
9. Johanson W., Pierce A., Sanford J. Changing pharyngeal bacterial flora of hospitalized patients: Emergence of gram-negative bacilli. New Engl. J. Med. 281:1969;1137-1140.
10. Johanson W., Pierce A., Sanford J., et al. Nosocomial respiratory infections with gram-negative bacilli: The significance of colonization of the respiratory tract. Ann. Int. Med. 77:1972;701-706.
11. Domenico P., Johanson W., Straus D. Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae. Infect. Immun. 37:1982;327-335.
12. Held T., Trautmann M., Mielke M., Neudeck H., Cryz S.J., Cross A. Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumonia. Infect. Immun. 60:1992;1771-1778.
13. Tang H., DiMango E., Bryan R., Gambello M., Iglewski B., Goldberg J., Prince A. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect. Immun. 64:1996;37-43.
14. Reynolds H. Lung host defenses: a status report. Chest. 75:1979;S39-42.
15. Sibille Y., Reynolds H. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141:1990;471-501.
16. Standiford T., Huffnagle G. Cytokines in host defense against pneumonia. J. Invest. Med. 45:1997;335-345.
17. Goldman G., Welbourn R., Klausner J., Kobzik L., Valeri C., Shepro D., Hechtman H. Neutrophil accumulations due to pulmonary thromboxane synthesis mediate acid aspiration injury. J. Appl. Physiol. 70:1991;1511-1517.
18. Stephens K., Ishizaka A., Wu Z., Larrick J., Raffin T. Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs. Am. Rev. Respir. Dis. 138:1988;1300-1307.
19. Zimmerman J., Ringer T. Inflammatory host responses in sepsis. Crit. Care Med. 8:1992;163-189.
20. Meduri G. The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment. Eur. Respir. J. 9:1996;2650-2670.
21. Wiener-Kronish J., Sakuma T., Kudoh I., Pittet J.-P., Frank D., Dobbs L., Vasil M., Matthay M. Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J. Appl. Physiol. 75:1993;1661-1669.
22. Frank D., Nair G., Schweizer H. Construction and characterization of chromosomal insertion mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus. Infect. Immun. 62:1994;554-563.
23. Seeger W., et al. Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungs. Am. Rev. Respir. Dis. 143:1991;797-805.
24. Bhakdi S., Grimminger F., Suttorp N., Walmrath D., Seeger W. Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection. Med. Microbiol. Immunol. 183:1994;119-144.
25. Russo T., Guenther J., Wenderoth S., Frank M. Generation of isogenic K54 capsule-deficient Escherichia coli strains through TnphoA-mediated gene disruption. Mol. Microbiol. 9:1993;357-364.
26. Russo T., Sharma G., Brown C., Campagnari A. The loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo. Infect. Immun. 63:1995;1263-1269.
27. Russo T., Johnson J. A proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181:2000;1753-1754.
28. Russo T., Liang Y., Cross A. The presence of K54 capsular polysaccharide increases the pathogenicity of Escherichia coli in vivo. J. Infect. Dis. 169:1994;112-118.
29. Russo T., Brown J., Jodush S., Johnson J. The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence in an extraintestinal isolate of Escherichia coli. Infect. Immun. 64:1996;2343-2348.
30. Russo T., Wenderoth S., Carlino U., Merrick J., Lesse A. Identification, genomic organization and analysis of the group III capsular polysaccharide genes kpsD, kpsM, kpsT, and kpsE from an extraintestinal isolate of Escherichia coli (CP9, O4/K54/H5). J. Bacteriol. 180:1998;338-349.
31. Wang L., Qu W., Reeves P. Sequence analysis of four Shigella boydii O-antigen loci: Implication for Escherichia coli and Shigella relationships. Infect. Immun. 69:2001;6923-6930.
32. Russo T., Davidson B., Priore R., Carlino U., Helinski J., Knight P.I. Capsular polysaccharide and O-specific antigen divergently modulate pulmonary neutrophil influx in a rat Escherichia coli model of gram-negative pneumonitis. Infect. Immun. 68:2000;2854-2862.
33. Davidson B., Knight P., Helinski J., Nader N., Shanley T., Johnson K. The role of tumor necrosis factor-alpha in the pathogenesis of aspiration pneumonitis in rats. Anesthesiology. 91:1999;486-499.
34. Mayer, M. (1971) In: Experimental Immunochemistry (Kabat, E.A. and Mayer, M., Eds.), pp. 133-209. Thomas, Springfield, IL.
35. Knight P., Druskovich G., Tait A., et al. The role of neutrophils, oxidants and proteases in the pathogenesis of acid pulmonary injury. Anesthesiology. 77:1992;772-778.
36. Russo, T. (2002) In: Escherichia coli: Virulence Mechanisms of a Versatile Pathogen (Donnenberg, M., Ed.), pp. 379-403. Academic Press, London.
37. Russo T., Sharma G., Weiss J., Brown C. The construction and characterization of colanic acid deficient mutants in an extraintestinal isolate of Escherichia coli (O4/K54/H5). Microb. Pathog. 18:1995;269-278.
38. Russo T., Moffitt M., Hammer C., Frank M. TnphoA mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity. Infect. Immun. 61:1993;3578-3582.
39. Kurahashi K., Kajikawa O., Sawa T., Ohara M., Gropper M., Frank D., Martin T., Wiener-Kronish J. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J. Clin. Invest. 104:1999;743-750.
40. Deitch E. Animal models of sepsis and shock: A review and lessons learned. Shock. 9:1998;1-11.
41. Freeman B., et al. Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in rats. J. Appl. Physiol. 80:1996;2066-2076.